Editas Medicine
Patents, Design & Utilities
Last updated:
List of all Editas Medicine patents 62 in total
| Status | Patent |
|---|---|
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING CEP290-ASSOCIATED DISEASE Filling date: 14 Sep 2025 Issue date: 1 Sep 2022 |
Grant | Utility: CRISPR-related methods and compositions with governing gRNAS Filling date: 14 Sep 2025 Issue date: 19 Jul 2022 |
Grant | Utility: CRISPR/cas-related methods and compositions for treating herpes simplex virus Filling date: 14 Sep 2025 Issue date: 19 Jul 2022 |
Grant | Utility: Optimized CRISPR/cas9 systems and methods for gene editing in stem cells Filling date: 14 Sep 2025 Issue date: 19 Jul 2022 |
Application | Utility: CAS9 FUSION MOLECULES, GENE EDITING SYSTEMS, AND METHODS OF USE THEREOF Filling date: 14 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: CELLS EXPRESSING A RECOMBINANT RECEPTOR FROM A MODIFIED TGFBR2 LOCUS, RELATED POLYNUCLEOTIDES AND METHODS Filling date: 14 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: ENGINEERED CAS9 NUCLEASES Filling date: 14 Sep 2025 Issue date: 9 Jun 2022 |
Grant | Utility: Compositions and methods for treating CEP290-associated disease Filling date: 14 Sep 2025 Issue date: 24 May 2022 |
Application | Utility: MODIFIED NATURAL KILLER (NK) CELLS FOR IMMUNOTHERAPY Filling date: 14 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING USHER SYNDROME AND RETINITIS PIGMENTOSA Filling date: 14 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: CRISPR/RNA-GUIDED NUCLEASE-RELATED METHODS AND COMPOSITIONS FOR TREATING RHO-ASSOCIATED AUTOSOMAL-DOMINANT RETINITIS PIGMENTOSA (ADRP) Filling date: 14 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: CRISPR-CAS-RELATED METHODS, COMPOSITIONS AND COMPONENTS FOR CANCER IMMUNOTHERAPY Filling date: 14 Sep 2025 Issue date: 7 Apr 2022 |
Application | Utility: SYSTEMS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES Filling date: 14 Sep 2025 Issue date: 10 Mar 2022 |
Grant | Utility: CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amaurosis 10 (LCA10) Filling date: 14 Sep 2025 Issue date: 8 Mar 2022 |
Application | Utility: SYSTEMS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES Filling date: 14 Sep 2025 Issue date: 17 Feb 2022 |
Grant | Utility: CRISPR/CAS-related methods and compositions for treating sickle cell disease Filling date: 14 Sep 2025 Issue date: 8 Feb 2022 |
Grant | Utility: Cas9 fusion molecules, gene editing systems, and methods of use thereof Filling date: 14 Sep 2025 Issue date: 1 Feb 2022 |
Application | Utility: SYSTEMS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES Filling date: 14 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: SYSTEMS AND METHODS FOR ONE-SHOT GUIDE RNA (ogRNA) TARGETING OF ENDOGENOUS AND SOURCE DNA Filling date: 14 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING HERPES SIMPLEX VIRUS Filling date: 14 Sep 2025 Issue date: 13 Jan 2022 |
Application | Utility: CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS Filling date: 14 Sep 2025 Issue date: 9 Dec 2021 |
Application | Utility: CRISPR/CAS-RELATED METHODS AND COMPOSITIONS TARGETING VIRUS GENOMES Filling date: 14 Sep 2025 Issue date: 25 Nov 2021 |
Grant | Utility: Evaluation of Cas9 molecule/guide RNA molecule complexes Filling date: 14 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Compositions and methods for treating CEP290-associated disease Filling date: 14 Sep 2025 Issue date: 12 Oct 2021 |
Application | Utility: HPV-SPECIFIC BINDING MOLECULES Filling date: 14 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: SYNTHETIC GUIDE MOLECULES, COMPOSITIONS AND METHODS RELATING THERETO Filling date: 14 Sep 2025 Issue date: 2 Sep 2021 |
Grant | Utility: Engineered Cas9 nucleases Filling date: 14 Sep 2025 Issue date: 24 Aug 2021 |
Application | Utility: SYSTEMS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES Filling date: 14 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: SYSTEMS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES Filling date: 14 Sep 2025 Issue date: 29 Jul 2021 |
Grant | Utility: Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA Filling date: 14 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: CRISPR/CAS-related methods and compositions for treating cystic fibrosis Filling date: 14 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: CRISPR/Cas-related methods and compositions for treating Usher syndrome and retinitis pigmentosa Filling date: 14 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: CRISPR/Cas-related methods and compositions for treating herpes simplex virus Filling date: 14 Sep 2025 Issue date: 11 May 2021 |
Application | Utility: CRISPR/Cas9-Mediated Exon-Skipping Approach for USH2A-Associated Usher Syndrome Filling date: 14 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: SYSTEMS AND METHODS FOR MODULATING CHROMOSOMAL REARRANGEMENTS Filling date: 14 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: SELECTION METHODS Filling date: 14 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: CRISPR-RELATED METHODS AND COMPOSITIONS Filling date: 14 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: T CELLS EXPRESSING A RECOMBINANT RECEPTOR, RELATED POLYNUCLEOTIDES AND METHODS Filling date: 14 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING HERPES SIMPLEX VIRUS (HSV) RELATED KERATITIS Filling date: 14 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR TREATING CONE-ROD RETINAL DYSTROPHY Filling date: 14 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: SYSTEMS AND METHODS FOR TREATING HYPER-IGM SYNDROME Filling date: 14 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: CRISPR-RELATED METHODS AND COMPOSITIONS WITH GOVERNING gRNAS Filling date: 14 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: CPF1-RELATED METHODS AND COMPOSITIONS FOR GENE EDITING Filling date: 14 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: TARGETED INTEGRATION SYSTEMS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES Filling date: 14 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING BETA HEMOGLOBINOPATHIES Filling date: 14 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: METHODS OF ASSESSING NUCLEASE CLEAVAGE Filling date: 14 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: SYSTEMS AND METHODS FOR TREATING ALPHA 1-ANTITRYPSIN (A1AT) DEFICIENCY Filling date: 14 Sep 2025 Issue date: 9 Jul 2020 |
Application | Utility: METHODS AND SYSTEMS FOR ANALYZING GUIDE RNA MOLECULES Filling date: 14 Sep 2025 Issue date: 18 Jun 2020 |
Application | Utility: ASSESSING NUCLEASE CLEAVAGE Filling date: 14 Sep 2025 Issue date: 18 Jun 2020 |
Application | Utility: NUCLEIC ACID MUTAGENESIS METHODS Filling date: 14 Sep 2025 Issue date: 11 Jun 2020 |
Showing 1 to 50 of 62 patents.